Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI Summary - About
Koninklijke Philips NV ADR(PHG)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for PHG
09/28/2026: PHG (1-star) is currently NOT-A-BUY. Pass it for now.
Koninklijke Philips NV is a major global health technology provider, focusing on diagnostic imaging, connected care, and personal health. The company's strengths lie in its massive installed base of hospital hardware and strong consumer brands like Sonicare. Its primary growth story revolves around transitioning to recurring revenue through AI-integrated software and remote care services. However, the company faces material risks, including ongoing litigation and regulatory challenges stemming from past product recalls, as well as intense competition in medical hardware. The stock may suit value-oriented investors who are willing to navigate high volatility as the firm executes its multi-year recovery and restructuring strategy.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | The company offers exposure to health-tech secular trends but growth is currently tempered by operational restructuring. |
| Momentum investor | Weak fit | Momentum is currently inconsistent as the company works through legacy regulatory and litigation headwinds. |
| Value investor | Strong fit | Valuation may appear attractive for investors willing to look past current legal and operational noise toward a long-term recovery. |
| Dividend investor | Mixed fit | While dividends are paid, the sustainability and growth of payouts are currently constrained by significant litigation provisions. |
| Low-risk investor | Weak fit | The stock has exhibited high price volatility tied to product recall news and regulatory developments. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock is sensitive to unpredictable legal, regulatory, and product-related announcements. |
| Valuation risk | Medium | Valuation is often disconnected from fundamentals due to uncertainty surrounding long-term litigation liabilities. |
| Competition risk (Medical Technology) | Medium / high | Philips faces entrenched competition from larger and more focused medical conglomerates. |
| Business quality | Medium | The franchise remains strong in imaging, but operational execution has been challenged by past quality control issues. |
| Dividend income | Medium | Future dividend reliability depends on the successful resolution of substantial legal claims. |
| Execution risk | High | Management must simultaneously improve margins, restore quality control, and resolve multi-billion dollar litigation. |
Price Behavior
Downtrend
The stock has experienced a sustained decline in price over recent periods.
Smooth
The stock has moved along a generally orderly path with only modest fluctuations.
Analysis of Past Performance
Type Stock | Historic Profit -16.07% | Avg. Invested days 35 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/28/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 24.40B USD | Price to earnings Ratio 19.05 | 1Y Target Price 32.21 |
Price to earnings Ratio 19.05 | 1Y Target Price 32.21 | ||
Volume (30-day avg) 732.9K shares | Beta 0.91 | 52 Weeks Range 23.85 - 32.19 | Updated Date 09/27/2026 |
52 Weeks Range 23.85 - 32.19 | Updated Date 09/27/2026 | ||
Dividends yield (FY) 4.06% | Basic EPS (TTM) 1.31 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Diagnosis & Treatment | Diagnostic imaging equipment, interventional x-ray systems, and ultrasound solutions. | This is the company's capital-intensive backbone, selling high-end machinery to hospitals. |
| Connected Care | Patient monitoring, telehealth, and sleep/respiratory care devices. | This segment is focused on patient data and remote care, though it has been the primary source of recent recall risks. |
| Personal Health | Oral healthcare, beauty, and grooming products. | This provides a steady, consumer-facing revenue stream with strong brand loyalty. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE 19.05 | Forward PE 12.72 | Enterprise Value 30.99B | Price to Sales(TTM) 1.38 |
Enterprise Value 30.99B | Price to Sales(TTM) 1.38 | ||
Enterprise Value to Revenue 1.53 | Enterprise Value to EBITDA 8.98 | Shares Outstanding 977.43M | Shares Floating 976.62M |
Shares Outstanding 977.43M | Shares Floating 976.62M | ||
Percent Insiders - | Percent Institutions 5.42 |
Upturn AI Summary
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
About Koninklijke Philips NV ADR
Exchange NYSE | Headquarters - | ||
IPO Launch date 1987-12-30 | President, CEO & Chairman of the Board of Management Mr. Roy Willem Odilia Jakobs | ||
Sector Healthcare | Industry Medical Devices | Full time employees 63670 | Website https://www.philips.com |
Full time employees 63670 | Website https://www.philips.com | ||
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. Koninklijke Philips N.V. has strategic alliance with WellSpan Health to advanced imaging and diagnostics technology products and platforms. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.